ArticleThe Journal of clinical investigation2025
Targeting ubiquitin-independent proteasome with small molecule increases susceptibility in pan-KRAS-mutant cancer models.
Shihui Shen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.